Abstract
Background
Differentiating between self-resolving viral infections and bacterial infections in children who are febrile is a common challenge, causing difficulties in identifying which individuals require antibiotics. Studying the host response to infection can provide useful insights and can lead to the identification of biomarkers of infection with diagnostic potential. This study aimed to identify host protein biomarkers for future development into an accurate, rapid point-of-care test that can distinguish between bacterial and viral infections, by recruiting children presenting to health-care settings with fever or a history of fever in the previous 72 h.Methods
In this multi-cohort machine learning study, patient data were taken from EUCLIDS, the Swiss Pediatric Sepsis study, the GENDRES study, and the PERFORM study, which were all based in Europe. We generated three high-dimensional proteomic datasets (SomaScan and two via liquid chromatography tandem mass spectrometry, referred to as MS-A and MS-B) using targeted and untargeted platforms (SomaScan and liquid chromatography mass spectrometry). Protein biomarkers were then shortlisted using differential abundance analysis, feature selection using forward selection-partial least squares (FS-PLS; 100 iterations), along with a literature search. Identified proteins were tested with Luminex and ELISA and iterative FS-PLS was done again (25 iterations) on the Luminex results alone, and the Luminex and ELISA results together. A sparse protein signature for distinguishing between bacterial and viral infections was identified from the selected proteins. The performance of this signature was finally tested using Luminex assays and by calculating disease risk scores.Findings
376 children provided serum or plasma samples for use in the discovery of protein biomarkers. 79 serum samples were collected for the generation of the SomaScan dataset, 147 plasma samples for the MS-A dataset, and 150 plasma samples for the MS-B dataset. Differential abundance analysis, and the first round of feature selection using FS-PLS identified 35 protein biomarker candidates, of which 13 had commercial ELISA or Luminex tests available. 16 proteins with ELISA or Luminex tests available were identified by literature review. Further evaluation via Luminex and ELISA and the second round of feature selection using FS-PLS revealed a six-protein signature: three of the included proteins are elevated in bacterial infections (SELE, NGAL, and IFN-γ), and three are elevated in viral infections (IL18, NCAM1, and LG3BP). Performance testing of the signature using Luminex assays revealed area under the receiver operating characteristic curve values between 89·4% and 93·6%.Interpretation
This study has led to the identification of a protein signature that could be ultimately developed into a blood-based point-of-care diagnostic test for rapidly diagnosing bacterial and viral infections in febrile children. Such a test has the potential to greatly improve care of children who are febrile, ensuring that the correct individuals receive antibiotics.Funding
European Union's Horizon 2020 research and innovation programme, the European Union's Seventh Framework Programme (EUCLIDS), Imperial Biomedical Research Centre of the National Institute for Health Research, the Wellcome Trust and Medical Research Foundation, Instituto de Salud Carlos III, Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Grupos de Refeencia Competitiva, Swiss State Secretariat for Education, Research and Innovation.Full text links
Read article at publisher's site: https://doi.org/10.1016/s2589-7500(23)00149-8
Read article for free, from open access legal sources, via Unpaywall: http://www.thelancet.com/article/S2589750023001498/pdf
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/155768935
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/s2589-7500(23)00149-8
Article citations
Machine learning for catalysing the integration of noncoding RNA in research and clinical practice.
EBioMedicine, 106:105247, 18 Jul 2024
Cited by: 0 articles | PMID: 39029428 | PMCID: PMC11314885
Review Free full text in Europe PMC
Application of a Machine Learning-Based Classification Approach for Developing Host Protein Diagnostic Models for Infectious Disease.
Diagnostics (Basel), 14(12):1290, 18 Jun 2024
Cited by: 0 articles | PMID: 38928705
Antimicrobial Stewardship in Pediatric Emergency Medicine: A Narrative Exploration of Antibiotic Overprescribing, Stewardship Interventions, and Performance Metrics.
Children (Basel), 11(3):276, 23 Feb 2024
Cited by: 2 articles | PMID: 38539311 | PMCID: PMC10968970
Review Free full text in Europe PMC
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study.
Lancet Child Adolesc Health, 8(5):325-338, 19 Mar 2024
Cited by: 1 article | PMID: 38513681
Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children.
JAMA, 316(8):835-845, 01 Aug 2016
Cited by: 173 articles | PMID: 27552617 | PMCID: PMC5997174
A Novel Combination of Host Protein Biomarkers to Distinguish Bacterial From Viral Infections in Febrile Children in Emergency Care.
Pediatr Infect Dis J, 42(7):e235-e242, 17 May 2023
Cited by: 1 article | PMID: 37200500
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification
CRC Press/Taylor & Francis, Boca Raton (FL), 14 Aug 2015
Cited by: 0 articles | PMID: 26269925
ReviewBooks & documents Free full text in Europe PMC
Funding
Funders who supported this work.
MRF (1)
Grant ID: MRF_MRF-160-0008-ELP-KAFO-C0801
Medical Research Foundation (1)
Emerging Leaders Prize – 1st Place Winner
Dr Myrsini Kaforou, Imperial College London
Grant ID: MRF-160-0008-ELP-KAFO-C0801
National Institute for Health Research (NIHR) (1)
Grant ID: CL-2017-17-006
Wellcome Trust (2)
Understanding and diagnosing infectious diseases using multi-level 'omics data
Dr Myrsini Kaforou, Imperial College London
Grant ID: 206508/Z/17/Z
Grant ID: 215214/Z/19/Z